NCT00004406CompletedNot Applicable
Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Columbia University
- Enrollment
- 36
- Locations
- 1
Study Overview
Brief Summary
OBJECTIVES:
I. Determine the effect of human parathyroid hormone (1-34) on bone mass in middle-aged men with idiopathic osteoporosis.
Detailed Description
PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled study. All patients self-administer daily subcutaneous injections of human parathyroid hormone (1-34) or placebo for a period of 2.5 years.
Patients are followed regularly for unacceptable toxicities.
Completion date provided represents the completion date of the grant per OOPD records
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 29 Years to 67 Years (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Impact of Parathyroid Hormone (PTH) on Osseous CavityBone LossPeriodontitisNCT00277706University of Michigan40
Completed
Phase 2
Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal WomenOsteoporosisPostmenopausal OsteoporosisNCT00086619Massachusetts General Hospital80
Withdrawn
Phase 1
One Week Comparison Study of PTH and PTHrP InfusionsHypercalcemia of MalignancyBone Diseases, EndocrineOsteoporosisHyperparathyroidismNCT01333267University of Pittsburgh
Not yet recruiting
Not Applicable
The Bone-parathyroid Crosstalk in Primary HyperparathyroidismHyperparathyroidism, PrimaryParathyroid NeoplasmsOsteoporosisNCT05556499I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio100
Completed
Phase 2
Bone Properties in Hypoparathyroidism: Effects of PTHHypoparathyroidismNCT00473265John P. Bilezikian68